Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 38

    1.

    Effects of pterostilbene on melanoma alone and in synergy with inositol hexaphosphate.

    Schneider JG, Alosi JA, McDonald DE, McFadden DW.

    Am J Surg. 2009 Nov;198(5):679-84.PMID: 19887199 [PubMed - in process]Related articles

    2.

    The proline 12 alanine substitution in the PPARgamma2 gene is associated with increased extent of coronary artery disease in men.

    Schneider JG, Schiekofer S, Eynatten M, Schlimmer P, Dugi KA.

    Exp Clin Endocrinol Diabetes. 2009 Oct;117(9):519-21. Epub 2009 Jun 17.PMID: 19536733 [PubMed - in process]Related articles

    3.

    PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients: response to Regieli et al.

    Schneider JG, Schiekofer S, von Eynatten M, Dugi KA.

    Diabetes Care. 2009 Jun;32(6):e75; author reply e76. No abstract available. PMID: 19460911 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Human ehrlichiosis: a case study.

    Schneider JG.

    Clin Lab Sci. 2009 Winter;22(1):3-8.PMID: 19354021 [PubMed - indexed for MEDLINE]Related articles

    5.

    Endothelial Lipase: a key player in HDL metabolism modulates inflammation and atherosclerotic risk.

    DeSantis P, Coleman T, Schiekofer S, Nawroth PP, Schlimmer P, Schneider JG.

    Mini Rev Med Chem. 2008 Jun;8(6):619-27. Review.PMID: 18537717 [PubMed - indexed for MEDLINE]Related articles

    6.

    Angiogenic-regulatory network revealed by molecular profiling heart tissue following Akt1 induction in endothelial cells.

    Schiekofer S, Belisle K, Galasso G, Schneider JG, Boehm BO, Burster T, Schmitz G, Walsh K.

    Angiogenesis. 2008;11(3):289-99. Epub 2008 May 20.PMID: 18491207 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease.

    Gates AC, Bernal-Mizrachi C, Chinault SL, Feng C, Schneider JG, Coleman T, Malone JP, Townsend RR, Chakravarthy MV, Semenkovich CF.

    Cell Metab. 2007 Dec;6(6):497-505.PMID: 18054318 [PubMed - indexed for MEDLINE]Related articles

    8.

    Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.

    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.

    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2699-706. Epub 2007 Oct 19. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):e12. PMID: 17951320 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Grb2 is required for atherosclerotic lesion formation.

    Proctor BM, Ren J, Chen Z, Schneider JG, Coleman T, Lupu TS, Semenkovich CF, Muslin AJ.

    Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1361-7. Epub 2007 Mar 15.PMID: 17363695 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation.

    Ren J, Avery J, Zhao H, Schneider JG, Ross FP, Muslin AJ.

    J Mol Cell Cardiol. 2007 Feb;42(2):367-77. Epub 2006 Dec 20.PMID: 17184791 [PubMed - indexed for MEDLINE]Related articles

    11.

    ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.

    Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, Bernal-Mizrachi C, Muslin AJ, Kastan MB, Semenkovich CF.

    Cell Metab. 2006 Nov;4(5):377-89.PMID: 17084711 [PubMed - indexed for MEDLINE]Related articles

    12.

    The metabolic syndrome in women.

    Schneider JG, Tompkins C, Blumenthal RS, Mora S.

    Cardiol Rev. 2006 Nov-Dec;14(6):286-91. Review.PMID: 17053375 [PubMed - indexed for MEDLINE]Related articles

    13.

    Swelling and weakness.

    Schneider JG, Troy P, Sosnay PR.

    Am J Med. 2006 Jul;119(7):574-6. No abstract available. PMID: 16828626 [PubMed - indexed for MEDLINE]Related articles

    14.

    Postprandial mononuclear NF-kappaB activation is independent of the AGE-content of a single meal.

    Schiekofer S, Franke S, Andrassy M, Chen J, Rudofsky G, Schneider JG, von Eynatten M, Wendt T, Morcos M, Kientsch-Engel R, Stein G, Schleicher E, Nawroth PP, Bierhaus A.

    Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):160-7.PMID: 16705547 [PubMed - indexed for MEDLINE]Related articles

    15.

    Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men.

    von Eynatten M, Schneider JG, Humpert PM, Kreuzer J, Kuecherer H, Katus HA, Nawroth PP, Dugi KA.

    J Am Coll Cardiol. 2006 May 16;47(10):2124-6. Epub 2006 Apr 24. No abstract available. PMID: 16697337 [PubMed - indexed for MEDLINE]Related articles

    16.

    PPARalpha: savior or savage?

    Schneider JG, Semenkovich CF.

    Cell Metab. 2005 Dec;2(6):341-2. No abstract available. PMID: 16330317 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of adiponectin in atherosclerosis: do lipids tip the scales?

    von Eynatten M, Schneider JG.

    Future Cardiol. 2005 Nov;1(6):775-84.PMID: 19804051 [PubMed - in process]

    18.

    Atorvastatin increases lipoprotein lipase expression in vitro and activity in vivo.

    Schneider JG, Eynatten MV, Dugi KA.

    J Atheroscler Thromb. 2005;12(4):232-3. No abstract available. PMID: 16148403 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo.

    Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA.

    Diabetes Care. 2005 Sep;28(9):2181-6.PMID: 16123487 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.

    Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF.

    Cell Metab. 2005 May;1(5):309-22.PMID: 16054078 [PubMed - indexed for MEDLINE]Related articles

    21.

    Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes.

    von Eynatten M, Schneider JG, Hadziselimovic S, Hamann A, Bierhaus A, Nawroth PP, Dugi KA.

    Diabetes Care. 2005 Mar;28(3):754-5. No abstract available. PMID: 15735224 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.

    Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundörfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP.

    J Clin Invest. 2004 Dec;114(12):1741-51.PMID: 15599399 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.

    von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA.

    Diabetes Care. 2004 Dec;27(12):2925-9.PMID: 15562208 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.

    Schneider JG, von Eynatten M, Parhofer KG, Volkmer JE, Schiekofer S, Hamann A, Nawroth PP, Dugi KA.

    Atherosclerosis. 2004 Aug;175(2):325-31.PMID: 15262189 [PubMed - indexed for MEDLINE]Related articles

    25.

    A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes.

    Rudofsky G Jr, Isermann B, Schilling T, Schiekofer S, Andrassy M, Schneider JG, Morcos M, Humpert PM, Sayed AA, Witte S, Renn W, Pfohl M, Hamann A, Nosikov V, Schleicher E, Häring HU, Rudofsky G, Ritz E, Nawroth PP, Bierhaus A.

    Exp Clin Endocrinol Diabetes. 2004 Mar;112(3):135-41.PMID: 15052533 [PubMed - indexed for MEDLINE]Related articles

    26.

    Endothelin-1 levels in patients with disorders of the thyroid gland.

    Tilly N, Schneider JG, Leidig-Bruckner G, Sommer U, Kasperk C.

    Exp Clin Endocrinol Diabetes. 2003 Apr;111(2):80-4.PMID: 12746758 [PubMed - indexed for MEDLINE]Related articles

    27.

    Elevated plasma endothelin-1 levels in diabetes mellitus.

    Schneider JG, Tilly N, Hierl T, Sommer U, Hamann A, Dugi K, Leidig-Bruckner G, Kasperk C.

    Am J Hypertens. 2002 Nov;15(11):967-72.PMID: 12441216 [PubMed - indexed for MEDLINE]Related articles

    28.

    Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.

    Schneider JG, Schaefer S, Lettgen B, Keiper T, Nawroth PP, Dugi KA.

    Lancet. 2002 Oct 12;360(9340):1150. No abstract available. PMID: 12387965 [PubMed - indexed for MEDLINE]Related articles

    29.

    Recurrent deep venous thrombosis caused by congenital interruption of the inferior vena cava and heterozygous factor V Leiden mutation.

    Schneider JG, Eynatten MV, Dugi KA, Duex M, Nawroth PP.

    J Intern Med. 2002 Sep;252(3):276-80.PMID: 12270010 [PubMed - indexed for MEDLINE]Related articles

    30.

    Low hepatic lipase activity is a novel risk factor for coronary artery disease.

    Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J.

    Circulation. 2001 Dec 18;104(25):3057-62.PMID: 11748100 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability.

    Keiper T, Schneider JG, Dugi KA.

    J Lipid Res. 2001 Aug;42(8):1180-6.PMID: 11483618 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Designing a fair and legally defensible process for board certification.

    Stromberg CD, Schneider JG.

    J Am Vet Med Assoc. 1994 Dec 15;205(12):1664-8. No abstract available. PMID: 7744637 [PubMed - indexed for MEDLINE]Related articles

    33.

    Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.

    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.

    Bone Marrow Transplant. 1994 Dec;14(6):877-84.PMID: 7536069 [PubMed - indexed for MEDLINE]Related articles

    34.

    Intraperitoneal chemotherapy.

    Schneider JG.

    Obstet Gynecol Clin North Am. 1994 Mar;21(1):195-212. Review.PMID: 8015764 [PubMed - indexed for MEDLINE]Related articles

    35.

    Ex vivo expansion of CD34+ hematopoietic progenitors.

    Moore MA, Schneider JG, Shapiro F, Bengala C.

    Prog Clin Biol Res. 1994;389:217-28. No abstract available. PMID: 7535432 [PubMed - indexed for MEDLINE]Related articles

    36.

    Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.

    Kritz A, Crown JP, Motzer RJ, Reich LM, Heller G, Moore MP, Hamilton N, Yao TJ, Heelan RT, Schneider JG, et al.

    Cancer. 1993 Apr 15;71(8):2515-21.PMID: 8095854 [PubMed - indexed for MEDLINE]Related articles

    37.

    Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.

    Muench MO, Schneider JG, Moore MA.

    Exp Hematol. 1992 Mar;20(3):339-49.PMID: 1373685 [PubMed - indexed for MEDLINE]Related articles

    38.

    [Dental care organization in a military health service unit]

    Schneider JG.

    Chir Dent Fr. 1990 Feb 8;60(505):47-50. French. No abstract available. PMID: 2387169 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...